Oscar Health Enters $250M Exchange Agreement with Oasis

Oscar Health ( (OSCR) ) has provided an update.

On November 3, 2025, Oscar Health entered into an exchange agreement with Oasis FD Holdings, LP, allowing the exchange of up to $250 million of its convertible senior notes for shares and cash, with $187.5 million already exchanged by November 5, 2025. This move is part of Oscar’s strategy to manage its capital structure and reduce future interest obligations. Additionally, Oscar reported its third-quarter 2025 financial results, showing increased revenue but also higher losses compared to the previous year, reaffirming its full-year 2025 guidance and highlighting its focus on market expansion and cost management.

The most recent analyst rating on (OSCR) stock is a Hold with a $19.50 price target. To see the full list of analyst forecasts on Oscar Health stock, see the OSCR Stock Forecast page.

Spark’s Take on OSCR Stock

According to Spark, TipRanks’ AI Analyst, OSCR is a Neutral.

Oscar Health’s overall stock score reflects its strong revenue growth and improving cash flows, but is weighed down by ongoing profitability challenges and a negative P/E ratio. Technical indicators show a positive short-term trend, but valuation concerns and operational losses highlighted in the earnings call temper the outlook.

To see Spark’s full report on OSCR stock, click here.

More about Oscar Health

Oscar Health, Inc. operates in the health insurance industry, focusing on providing affordable and innovative health plans primarily for individuals, small businesses, and sectors such as service and farming. The company aims to expand its market share through disciplined pricing and geographic expansion, with a goal to return to profitability by 2026.

Average Trading Volume: 17,044,946

Technical Sentiment Signal: Buy

Current Market Cap: $4.44B

For detailed information about OSCR stock, go to TipRanks’ Stock Analysis page.